Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Lung Cancer treatment details. Chemotherapy. Radiation. Surgery. University Hospital Ghent, Gent, Belgium

Survival: 17.5 months
Toxicity Grade: 4
Treatments: Chemotherapy
Country: Belgium
City/State/Province: Gent
Hospital: University Hospital Ghent
Journal: Link
Date: 3/2007

Patients: This study involved 579 patients with stage IIIA-N2 non-small cell lung cancer. Of these, 74% were men and 26% were women. The median age was 61 years.

Treatment: All patients were given treatment with the chemotherapy drugs cisplatin or carboplatin in addition to at least one other drug. After chemotherapy, 167 had surgical resection and 165 had radiotherapy.

Toxicity: Grade 3/4 esophageal toxicity occurred in 1 patient, and grade 3/4 pulmonary toxic effects were observed in 5 patients. 11 patients had late pulmonary fibrosis and esophageal fibrosis occurred in 1 patient. One patient died of radiation pneumonitis.

Results: The median overall survival was 16.4 months for those receiving the surgical resection and 17.5 months for those receiving radiotherapy.

Support: this research was supported in part by educational grants from Eli Lilly, Bristol-Myers Squibb, and Aventis. One author has received research support from Eli Lilly and company, participated in their advisory board meetings and in their speakerís bureau.

Correspondence: Dr. Jan P. van Meerbeeck

E-mail to a Friend Email Physician More Information